CAS 2313526-86-0

N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide

CAS: 2313526-86-0

Formula: C₂₁H₁₉F₃N₄O₄

Purezza: 99.74%

Peso molecolare: 448.3952

Ref: IN-DA01KL03

N-(2-(1H-1,2,4-Triazol-1-Yl)-5-(Trifluoromethoxy)Phenyl)-4-(Cyclopropylmethoxy)-3-Methoxybenzamide

CAS: 2313526-86-0

N-(2-(1H-1,2,4-Triazol-1-Yl)-5-(Trifluoromethoxy)Phenyl)-4-(Cyclopropylmethoxy)-3-Methoxybenzamide

Formula: C₂₁H₁₉F₃N₄O₄

Purezza: 98%

Peso molecolare: 448.4

Ref: 54-PC108428

VU6012962

CAS: 2313526-86-0

VU6012962

Formula: C₂₁H₁₉F₃N₄O₄

Purezza: ≥95%

Peso molecolare: 448.4

Ref: 54-BUP12600

VU6012962

CAS: 2313526-86-0

N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide

Formula: C₂₁H₁₉F₃N₄O₄

Purezza: 98%

Peso molecolare: 448.4

Ref: IN-DG01100275

N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide

CAS: 2313526-86-0

N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide is a modulator of metabotropic glutamate receptors. It has been shown to be orally bioavailable and to have an effect on the spinal cord. This drug is effective in doses ranging from 1 mg/kg to 10 mg/kg. N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide is still in preclinical stages and has not been tested on humans yet.

Formula: C₂₁H₁₉F₃N₄O₄

Purezza: Min. 95%

Peso molecolare: 448.4 g/mol

Ref: 3D-NSD52686

VU6012962

CAS: 2313526-86-0

VU6012962 is an orally bioavailable negative allosteric modulator of CNS-penetrant metabotropic glutamate receptor 7(mGlu7; IC50: 347 nM).

Formula: C₂₁H₁₉F₃N₄O₄

Purezza: 99.61% - 99.74%

Colore e forma: Solid

Peso molecolare: 448.4

Ref: TM-T13323